000 01176 a2200337 4500
005 20250513192721.0
264 0 _c19991004
008 199910s 0 0 eng d
022 _a0025-729X
024 7 _a10.5694/j.1326-5377.1999.tb123595.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aShiell, A
245 0 0 _aHepatitis C: an economic evaluation of extended treatment with interferon.
_h[electronic resource]
260 _bThe Medical journal of Australia
_cAug 1999
300 _a189-93 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntiviral Agents
_xeconomics
650 0 4 _aAustralia
650 0 4 _aCost-Benefit Analysis
650 0 4 _aDecision Support Techniques
650 0 4 _aHepatitis C, Chronic
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aInterferon-alpha
_xeconomics
650 0 4 _aMarkov Chains
650 0 4 _aQuality of Life
650 0 4 _aQuality-Adjusted Life Years
700 1 _aBrown, S
700 1 _aFarrell, G C
773 0 _tThe Medical journal of Australia
_gvol. 171
_gno. 4
_gp. 189-93
856 4 0 _uhttps://doi.org/10.5694/j.1326-5377.1999.tb123595.x
_zAvailable from publisher's website
999 _c10451538
_d10451538